Hello everyone, I own a bit of $VVOS and am wondering whether I should sell after the stock price rose by 800% today due to FDA approval of a treatment to sleep apnea. This is the first approval from the FDA for a device to treat patients with severe obstructive sleep apnea without CPAP or surgical neurostimulation implants, but I'm not sure how important this is really is – is there any advantage to this compared to CPAP? Looking forward to hearing everyone's thoughts – I don't understand much about biotech.
Leave a Reply